Date Initiated by Firm | September 26, 2023 |
Date Posted | November 03, 2023 |
Recall Status1 |
Open3, Classified |
Recall Number | Z-0131-2024 |
Recall Event ID |
93074 |
Product Classification |
Injector and syringe, angiographic - Product Code DXT
|
Product | 30 ML 2PORT BURETTE ASSEMBLY, Article No. 7A3950, used in a contrast management system. |
Code Information |
UDI-DI: N/A
Lots 0061766049
|
Recalling Firm/ Manufacturer |
B. Braun Medical, Inc. 901 Marcon Blvd Allentown PA 18109-9512
|
For Additional Information Contact | BBMI Postmarket Surveillance Department 888-425-1464 |
Manufacturer Reason for Recall | Devices may leak as a result of a manufacturing issue. Leakage may result in a delay of therapy, increase risk of bloodstream infection (BSI), and may expose both patients and healthcare workers to hazardous medication. There is also the potential for life-threatening situations to occur requiring additional medical intervention. |
FDA Determined Cause 2 | Process control |
Action | On September 26, 2023, the firm notified customers via Urgent Product Recall Notification letters. Customers were informed of the potential for leakage at the male Luer lock site.
Customers were instructed to report total amount of impacted product on hand to the firm, after which B Braun Customer Support will contact the customer with instructions on how to return the product for credit or replacement depending on the customer's need.
Questions about this recall may be reported to BBMI s Postmarket Surveillance Department by calling 1-833-425-1464. |
Quantity in Commerce | 350 units |
Distribution | Worldwide distribution - US Nationwide and the countries of Canada and Singapore. |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|